Abbott India Limited (ABBOTINDIA.NS)
INR 28755.5
(2.3%)
INR 28755.5
(2.3%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 565.30 INR | 26.52% |
| 2022 | 446.80 INR | 18.87% |
| 2021 | 375.87 INR | 15.64% |
| 2020 | 325.04 INR | 16.49% |
| 2019 | 279.04 INR | 31.67% |
| 2018 | 211.93 INR | 12.25% |
| 2017 | 188.81 INR | 45.03% |
| 2016 | 130.19 INR | 8.38% |
| 2015 | 120.12 INR | 11.48% |
| 2014 | 107.75 INR | 37.31% |
| 2013 | 78.47 INR | 15.23% |
| 2012 | 68.10 INR | 20.19% |
| 2011 | 56.66 INR | 27.15% |
| 2010 | 44.56 INR | -21.38% |
| 2009 | 56.68 INR | 29.94% |
| 2008 | 43.62 INR | -5.19% |
| 2007 | 46.01 INR | 17.43% |
| 2006 | 39.18 INR | 1.19% |
| 2005 | 38.72 INR | -42.14% |
| 2004 | 66.92 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 154.36 INR | 14.26% |
| 2023 Q1 | 136.59 INR | 25.42% |
| 2023 FY | - INR | 26.52% |
| 2023 Q4 | 135.09 INR | -7.69% |
| 2023 Q3 | 146.35 INR | -0.62% |
| 2023 Q2 | 147.27 INR | 7.82% |
| 2022 FY | - INR | 18.87% |
| 2022 Q1 | 96.77 INR | -2.74% |
| 2022 Q2 | 124.95 INR | 29.12% |
| 2022 Q3 | 116.16 INR | -7.03% |
| 2022 Q4 | 108.91 INR | -6.24% |
| 2021 FY | - INR | 15.64% |
| 2021 Q4 | 99.50 INR | 6.14% |
| 2021 Q3 | 93.74 INR | 3.57% |
| 2021 Q2 | 90.51 INR | -1.75% |
| 2021 Q1 | 92.12 INR | 28.39% |
| 2020 FY | - INR | 16.49% |
| 2020 Q3 | 83.36 INR | -1.99% |
| 2020 Q4 | 71.75 INR | -13.93% |
| 2020 Q2 | 85.05 INR | 0.21% |
| 2020 Q1 | 84.87 INR | 62.52% |
| 2019 Q4 | 52.22 INR | -40.56% |
| 2019 FY | - INR | 31.67% |
| 2019 Q1 | 55.03 INR | 3.3% |
| 2019 Q2 | 83.92 INR | 52.5% |
| 2019 Q3 | 87.85 INR | 4.68% |
| 2018 FY | - INR | 12.25% |
| 2018 Q1 | 38.78 INR | -17.66% |
| 2018 Q3 | 55.08 INR | -14.99% |
| 2018 Q2 | 64.79 INR | 67.07% |
| 2018 Q4 | 53.27 INR | -3.29% |
| 2017 FY | - INR | 45.03% |
| 2017 Q2 | 64.72 INR | 184.98% |
| 2017 Q4 | 47.10 INR | -13.26% |
| 2017 Q3 | 54.30 INR | -16.1% |
| 2017 Q1 | 22.71 INR | 14.75% |
| 2016 Q2 | 35.30 INR | 1.35% |
| 2016 FY | - INR | 8.38% |
| 2016 Q3 | 40.26 INR | 14.05% |
| 2016 Q1 | 34.83 INR | 25.47% |
| 2016 Q4 | 19.79 INR | -50.84% |
| 2015 Q1 | 31.56 INR | 34.76% |
| 2015 FY | - INR | 11.48% |
| 2015 Q3 | 31.78 INR | 10.89% |
| 2015 Q4 | 27.76 INR | -12.65% |
| 2015 Q2 | 28.66 INR | -9.19% |
| 2014 Q3 | 30.37 INR | 1.23% |
| 2014 FY | - INR | 37.31% |
| 2014 Q2 | 30.00 INR | 25.16% |
| 2014 Q1 | 23.97 INR | 32.65% |
| 2014 Q4 | 23.42 INR | -22.88% |
| 2013 Q2 | 21.27 INR | 52.15% |
| 2013 Q3 | 25.16 INR | 18.29% |
| 2013 Q4 | 18.07 INR | -28.18% |
| 2013 FY | - INR | 15.23% |
| 2013 Q1 | 13.98 INR | -6.3% |
| 2012 Q3 | 23.42 INR | 29.82% |
| 2012 Q1 | 13.89 INR | 8.94% |
| 2012 Q2 | 18.04 INR | 29.88% |
| 2012 Q4 | 14.92 INR | -36.29% |
| 2012 FY | - INR | 20.19% |
| 2011 Q3 | 17.36 INR | -15.44% |
| 2011 Q4 | 12.75 INR | -26.56% |
| 2011 Q2 | 20.53 INR | 0.0% |
| 2011 FY | - INR | 27.15% |
| 2010 FY | - INR | -21.38% |
| 2009 FY | - INR | 29.94% |
| 2008 FY | - INR | -5.19% |
| 2007 FY | - INR | 17.43% |
| 2006 FY | - INR | 1.19% |
| 2005 FY | - INR | -42.14% |
| 2004 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Cipla Limited | 51.05 INR | -1007.346% |
| Gland Pharma Limited | 46.90 INR | -1105.33% |
| GlaxoSmithKline Pharmaceuticals Limited | 34.83 INR | -1523.026% |
| Kopran Limited | 10.57 INR | -5248.155% |
| Marksans Pharma Limited | 6.92 INR | -8069.075% |
| NGL Fine-Chem Limited | 66.88 INR | -745.245% |
| Pfizer Limited | 120.51 INR | -369.09% |
| Sanofi India Limited | 261.78 INR | -115.945% |
| SMS Pharmaceuticals Limited | 5.89 INR | -9497.623% |
| TTK Healthcare Limited | 44.47 INR | -1171.194% |